Amy K. Kim

1.8k total citations · 1 hit paper
28 papers, 976 citations indexed

About

Amy K. Kim is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Amy K. Kim has authored 28 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Amy K. Kim's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Amy K. Kim is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Amy K. Kim collaborates with scholars based in United States, Australia and Taiwan. Amy K. Kim's co-authors include Timothy M. Pawlik, Ihab R. Kamel, Mounes Aliyari Ghasebeh, Sean M. Ronnekleiv‐Kelly, Miral S. Grandhi, Lisa M. DeAngelis, Lauren E. Abrey, Antonio Omuro, Leah Ben‐Porat and Denise D. Correa and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Amy K. Kim

25 papers receiving 962 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocellular carcinoma: From diagnosis to treatment

2016 361 citations Miral S. Grandhi, Amy K. Kim et al. Surgical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy K. Kim United States	12	269	263	237	225	216	28	976
Ana Custodio Spain	21	301 1.1×	705 2.7×	175 0.7×	39 0.2×	306 1.4×	75	1.2k
Enxiao Li China	17	340 1.3×	671 2.6×	213 0.9×	302 1.3×	334 1.5×	45	1.2k
Dulabh Monga United States	15	396 1.5×	539 2.0×	119 0.5×	158 0.7×	227 1.1×	74	1.1k
Preston D. Steen United States	18	259 1.0×	579 2.2×	129 0.5×	51 0.2×	329 1.5×	47	1.0k
Huiqiang Huang China	16	218 0.8×	352 1.3×	93 0.4×	32 0.1×	90 0.4×	79	819
Xueshuai Wan China	19	421 1.6×	356 1.4×	365 1.5×	96 0.4×	266 1.2×	50	1.1k
Erwan Pencreach France	17	323 1.2×	350 1.3×	248 1.0×	62 0.3×	200 0.9×	35	797
Alessandro Bittoni Italy	23	437 1.6×	935 3.6×	479 2.0×	170 0.8×	488 2.3×	93	1.5k
Kota Arima Japan	19	259 1.0×	644 2.4×	260 1.1×	128 0.6×	211 1.0×	71	1.1k

Countries citing papers authored by Amy K. Kim

Since Specialization

Citations

This map shows the geographic impact of Amy K. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy K. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy K. Kim more than expected).

Fields of papers citing papers by Amy K. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy K. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy K. Kim. The network helps show where Amy K. Kim may publish in the future.

Co-authorship network of co-authors of Amy K. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Amy K. Kim. A scholar is included among the top collaborators of Amy K. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy K. Kim. Amy K. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gürakar, Merve, et al.. (2025). Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations

Kim, Amy K., Mark Yarchoan, Marina Baretti, et al.. (2025). Safety and efficacy of combining PD-L1 and CTLA-4 blockade with transarterial chemoembolization in intermediate-stage hepatocellular carcinoma: A phase II study.. Journal of Clinical Oncology. 43(4_suppl). 609–609.

Mohseni, Alireza, Azarakhsh Baghdadi, Seyedeh Panid Madani, et al.. (2024). Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters. Abdominal Radiology. 49(8). 2595–2605. 1 indexed citations

Tabrizian, Parissa, Matthew L. Holzner, Veeral Ajmera, et al.. (2024). Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study. Journal of Hepatology. 82(3). 512–522. 23 indexed citations

Mohseni, Alireza, Ziyi Xu, Mohammadreza Shaghaghi, et al.. (2024). Screening for exclusion of high-risk bleeding features of esophageal varices in cirrhosis through CT and MRI. Clinical Imaging. 110. 110168–110168. 3 indexed citations

Kim, Amy K., et al.. (2023). Impact of Cell-Debris and Room-Temperature Storage on Urine Circulating Tumor DNA from Hepatocellular Carcinoma. Journal of Molecular Diagnostics. 25(12). 913–920. 2 indexed citations

Bruhm, Daniel C., Dimitrios Mathios, Zachariah H. Foda, et al.. (2023). Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer. Nature Genetics. 55(8). 1301–1310. 30 indexed citations

Lin, Selena Y., Wei Xia, Amy K. Kim, et al.. (2023). Novel urine cell-free DNA methylation markers for hepatocellular carcinoma. Scientific Reports. 13(1). 21585–21585. 6 indexed citations

Fan, Christopher, Ahyoung Kim, Sean Li, et al.. (2022). Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team. Journal of Cancer Research and Clinical Oncology. 149(2). 877–883. 6 indexed citations

10.

Baretti, Marina, Amy K. Kim, & Robert A. Anders. (2022). Expanding the immunotherapy roadmap for hepatocellular carcinoma. Cancer Cell. 40(3). 252–254. 11 indexed citations

11.

Ting, Peng–Sheng, Merve Gürakar, Sean Li, et al.. (2021). Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 17 indexed citations

12.

Garibaldi, Brian T., Pali D. Shah, Gigi Liu, et al.. (2020). Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. American Journal of Transplantation. 20(8). 2254–2259. 35 indexed citations

13.

Balaji, Aanika, Jiajia Zhang, Karthik Suresh, et al.. (2020). A multidisciplinary immune-related toxicity (IR-Tox) program for immune-related adverse events: A two-year experience.. Journal of Clinical Oncology. 38(15_suppl). e15074–e15074. 2 indexed citations

14.

Kim, Amy K., Faiz Gani, Andrew J. Layman, et al.. (2019). Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma. Cancer Immunology Research. 7(5). 805–812. 20 indexed citations

15.

Şimşek, Cem, et al.. (2019). Liquid Biopsy in Solid Malignancy. Genetic Testing and Molecular Biomarkers. 23(4). 284–296. 14 indexed citations

16.

Naidoo, Jarushka, Jiajia Zhang, Evan J. Lipson, et al.. (2019). A Multidisciplinary Toxicity Team for Cancer Immunotherapy–Related Adverse Events. Journal of the National Comprehensive Cancer Network. 17(6). 712–720. 71 indexed citations

17.

Yarchoan, Mark, Dongmei Xing, Haiying Xu, et al.. (2017). Characterization of the Immune Microenvironment in Hepatocellular Carcinoma. Clinical Cancer Research. 23(23). 7333–7339. 112 indexed citations

18.

Grandhi, Miral S., Amy K. Kim, Sean M. Ronnekleiv‐Kelly, et al.. (2016). Hepatocellular carcinoma: From diagnosis to treatment. Surgical Oncology. 25(2). 74–85. 361 indexed citations breakdown →

19.

Kim, Amy K. & Amit G. Singal. (2014). Health disparities in diagnosis and treatment of hepatocellular carcinoma. Clinical Liver Disease. 4(6). 143–145. 16 indexed citations

20.

Omuro, Antonio, Leah Ben‐Porat, Katherine S. Panageas, et al.. (2005). Delayed Neurotoxicity in Primary Central Nervous System Lymphoma. Archives of Neurology. 62(10). 1595–600. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact